Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
45.9 USD | +0.51% | +1.80% | +13.79% |
13/05 | Oppenheimer Adjusts Price Target on Soleno Therapeutics to $59 From $65, Maintains Outperform Rating | MT |
10/05 | Baird Starts Soleno Therapeutics With Outperform Rating, $72 Price Target | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+13.79% | 166.25Cr | |
+9.15% | 11TCr | |
+11.46% | 10TCr | |
-13.90% | 2.24TCr | |
-1.05% | 2.23TCr | |
-5.29% | 1.91TCr | |
-38.29% | 1.8TCr | |
-3.73% | 1.79TCr | |
+7.86% | 1.43TCr | |
+34.84% | 1.25TCr |
- Stock Market
- Equities
- SLNO Stock
- News Soleno Therapeutics, Inc.
- Oppenheimer Raises Soleno Therapeutics Price Target to $14 Form $8, Maintains Outperform Rating